Back to Resource Center

Opportunities and Challenges for Long-Acting MPTs

Opportunities and Challenges for Long-Acting MPTs

This is a live webinar featuring Dr. Charles Flexner (Johns Hopkins Medicine) who discusses employing long-acting delivery methods to develop an MPT with an HIV perspective and Dr. Arnab Chatterjee (California Institute for Biomedical Research, Calibr) who discusses defining and developing drug substances as relevant to technical requirements for long-acting MPTs.

• View Webinar Recording
• View Webinar Slides

May 2018

Click for full info +

Opportunities and Challenges for Long-Acting MPTs

Opportunities and Challenges for Long-Acting MPTs
02 May 2018

This is a live webinar featuring Dr. Charles Flexner (Johns Hopkins Medicine) who discusses employing long-acting delivery methods to develop an MPT with an HIV perspective and Dr. Arnab Chatterjee (California Institute for Biomedical Research, Calibr) who discusses defining and developing drug substances as relevant to technical requirements for long-acting MPTs.

• View Webinar Recording
• View Webinar Slides

Flexner, C. & Chatterjee, A.

In this Webinar:
Health Risk(s):

  • HIV
  • Unintended Pregnancy
    • Product Type(s):

  • HIV Treatment
  • MPTs
    • Topic(s):

  • Product Development


    • Full Info:


    Resource Type:

    Webinar

    Citation:

    This live webinar features Dr. Charles Flexner (Johns Hopkins Medicine) who discusses employing long-acting delivery methods to develop an MPT with an HIV perspective and Dr. Arnab Chatterjee (California Institute for Biomedical Research, Calibr) who discusses defining and developing drug substances as relevant to technical requirements for long-acting MPTs.

    Authors: Flexner, C. & Chatterjee, A.

    Health Risks(s):

    • HIV
    • Unintended Pregnancy

    Product type(s):

    • HIVtreatment
    • MPTs

    Topic(s):

    • Development

        Back to Resource Center